Logo of bmcpsycBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Psychiatry
BMC Psychiatry. 2007; 7: 23.
Published online Jun 8, 2007. doi:  10.1186/1471-244X-7-23
PMCID: PMC1906857

An animated depiction of major depression epidemiology

Abstract

Background

Epidemiologic estimates are now available for a variety of parameters related to major depression epidemiology (incidence, prevalence, etc.). These estimates are potentially useful for policy and planning purposes, but it is first necessary that they be synthesized into a coherent picture of the epidemiology of the condition. Several attempts to do so have been made using mathematical modeling procedures. However, this information is not easy to communicate to users of epidemiological data (clinicians, administrators, policy makers).

Methods

In this study, up-to-date data on major depression epidemiology were integrated using a discrete event simulation model. The mathematical model was animated in Virtual Reality Modeling Language (VRML) to create a visual, rather than mathematical, depiction of the epidemiology.

Results

Consistent with existing literature, the model highlights potential advantages of population health strategies that emphasize access to effective long-term treatment. The paper contains a web-link to the animation.

Conclusion

Visual animation of epidemiological results may be an effective knowledge translation tool. In clinical practice, such animations could potentially assist with patient education and enhanced long-term compliance.

Background

A comprehensive picture of the epidemiology of an episodic condition cannot be embodied in a single parameter such as an estimate of incidence or prevalence. The incidence of major depressive disorder conveys information about the risk of onset of an initial episode, but this is of limited value for clinical practice (where presentations occur after onset) or for public policy (since the rate of onset of new episodes does not adequately reflect the burden of disease). Prevalence is in some respects an even more obscure parameter. Prevalence is the number or proportion ("prevalence proportion") of population members who have a disorder at a point ("point prevalence") in time or during a period ("period prevalence") in time. This parameter is salient to the problem of quantifying disease burden but ultimately reflects a balance between entry into the prevalence pool (incidence or recurrence) and a other factors such as episode duration and mortality.

Attempts to integrate epidemiological estimates into a comprehensive "picture" of the epidemiology of major depression have used Markov models [1,2] and micro-simulation approaches [3]. The complexity of major depression epidemiology has required the development of fairly complex models, the mathematics of which may not be of great interest to many users of such information. A solution may be found in the use of modeling techniques that can be linked to visual depictions of the population dynamics. In this way, complex information can be processed visually, rather than by using equations, transition matrices etc. In this project, a set of plausible estimates for key parameters were extracted from available sources, supplemented by information from the international literature. These were combined using a simulation model, and a visual depiction of the epidemiology was produced in the form of an animation.

In a previous study, data from a longitudinal study called the National Population Health Survey (NPHS) was used to develop a prognosis calculator for major depression [4]. This prior project was similar to the current one in its use of a discrete event simulation modeling approach, but the previous analysis only examined the issue of episode duration. The current project uses the best available data from the literature rather than using data from a single survey source. It also attempts to integrate the various estimates into a more comprehensive description of the epidemiology.

Methods

Selection of epidemiological calibration targets for the simulation model

A set of values for key epidemiological parameters were selected in the development of the simulation model, based largely on existing literature. The objective was not to calibrate the model to a particular data set, but rather to use a set of reasonable values for the key parameters. Appendix I, see Additional file 1, presents more detailed information on the selection of specific parameter values. A summary is presented in Table Table1.1. In brief, lifetime prevalence was assumed to be approximately 20% for men and 30% for women, estimates put forward by Kruijshaar et al., taking into account the recall bias that almost certainly effects such estimates [3]. In some respects, these values may seem controversial, because they are higher than usually cited values, e.g. see a systematic review by Waraich et al. [5]. Andrews provides a review of evidence that the lifetime prevalence is probably much higher than has been traditionally believed [6]. The duration of episodes was assumed to follow a pattern whereby the longer an episode lasts, the lower the probability of recovery. A similar pattern was assumed, based on the literature, for episode-free intervals. The longer an episode of remission lasts, the lower the recurrence frequency. Again, this is consistent with Kruijshaar et al.'s work [3], which used lognormal and Weibull distributions to model these effects. More information about the basis for these assumptions is contained in Appendix I, see Additional file 1. The model also included entry into the population at risk and age-specific mortality risks reflecting those of the general population. Mortality was assumed to be increased in people who have had a major depressive episode, but only slightly so, with the relative risk for mortality being 1.1, a 10% increase relative to the general population. Again, additional detail about the selection of these parameters is in Appendix I, see Additional file 1.

Table 1
Targets for model calibration

Simulation strategy

The simulation model was programmed in software called Arena [7]. This software provides a graphical interface for development of SIMAN models using discrete event simulation. The model was set up so that simulated subjects or "entities" enter at age 15. Following Kruijshaar [3], the simulation began by assignment of a death date to each simulated entity (depicting a person), based on sex and age-specific mortality data for Canada, which was downloaded from the Statistics Canada website using an on-line data access utility called E-STAT [8]. Next, an incidence date was simulated using a cumulative Weibull distribution. This distribution was selected to reflect the expected decline in incidence with advancing age (see Additional file 1). When the incidence date occurred before the death date, an episode would occur during that subject's lifetime, and in this case the death date was recalculated using a relative risk for mortality of 1.1. A meta-analysis by Wulsin et al. [9] estimated the relative risk at 1.8, but this is almost certainly an overestimate as most of the studies included in the meta-analysis were clinical studies. A program called OptQuest, which is a part of the Arena package, was used to identify Weibull parameters (shape and scale) for incidence that were consistent both with estimates for the adolescent age group (which have been found to be very high in some studies, see Additional file 1), but diminishing at a sufficient rate to be consistent with the selected values for lifetime prevalence. OptQuest conducts a series of Monte Carlo simulations in order to identify parameters that closely fit modeling objectives.

A similar strategy was employed to simulate other elements in the model. Weibull distributions for episode duration, and the duration of remitted periods between episodes were identified. After resolution of an initial episode, the model entities moved into a first remission state. This approach resembles that of Kruijshaar et al. [3], except that Kruijshaar et al. [3] used lognormal distributions to describe episode duration. Previous work has determined that the Weibull distribution can also provide a good description [4]. OptQuest was used to find Weibull parameters for episode duration consistent with the selected calibration targets: approximately 15% recovered before three weeks, but approximately 15% are still not recovered after 2 years, see Appendix I for a more detailed discussion. Once appropriate values for these Weibull parameters were found, the relative risk of recurrence was sought, again using OptQuest, and calibrated to a targeted point prevalence of 1.8% [10].

In the model, when the simulated death date was reached, the entity left the simulation. Otherwise, subjects with depressive episodes continue to cycle between depressed and remitted states until their death date is reached. Eventually, a balance between entry and exit (death) is reached, and the various calibration parameters assume steady state values. In order to reach this state, the model was run for 250,000 days. This steady state allowed the model to be calibrated, using OptQuest as described above.

Making a visual animation

Arena can save the results of a simulation model into a file type (which Arena calls a "playback" file) that can be imported into a Virtual Reality Modeling Language (VRML) program and animated in three dimensions using a program called the Arena 3-D player. Video can be captured from the animation. The animations presented in this paper were captured as "avi" files, edited with addition of captions in a program called "Camtasia" and then saved as MacroMedia Flash files. These files were uploaded to the University of Calgary's Dspace under a Creative Commons license for open access. The Flash movie contains three parts. In the first part, the structure of the visual animation is presented. In the second part, the fully calibrated model is depicted. In the third section the model is animated with the recurrence pattern in subjects with multiple episodes having been changed to that of subjects with single episodes. The third part is a way of depicting the population health impact of highly effective tertiary prevention, ie. long-term treatment substantially reducing the relapse rate. The simulations were run at 500,000 times "real time." This means that each second in the simulation represents about six days of time. The rate of entry into the population was set so that approximately 1000 simulated people (entities) would be present in the simulation at steady state. In order that subjects could be seen moving from state to state, transitions were set to last for two weeks in simulation time. The two week transition time seems clinically reasonable, and avoids a problem that would arise in the animations if the transitions occurred too quickly to be seen easily.

Results

Table Table22 shows optimized parameters for the simulation model. The time units for the distributions are days. The Weibull parameters themselves are not readily interpretable. The cumulative Weibull distribution of time to a first episode, which was used, for example, to depict first incidence in these simulations is 1 – exp [-(time/a)b], where 'a' is the scale parameter and 'b' is the shape parameter. From these Weibull parameters, 'a' and 'b' it is possible to calculate age specific incidence rates as: b/a * (t/a)b-1. Here, time is in days with time = 0 being the time of entry into the model at age 15, so that time specific incidence can be rescaled to represent age specific incidence. Similarly, scale and shape parameters for episode duration, duration of first remission and duration of remission after multiple recurrences can be expressed more understandably as time specific recovery and recurrence rates.

Table 2
Optimized estimates: Weibull distributions*

The parameters for incidence translate into an average annualized incidence at age 16 (t = 365 days) of 1.7% for men and 4.0% for women. By age 25 (t = 3650) these rates decline to less than 1%. The incidence rates continue to decline with age, as depicted in Figure Figure1.1. The recovery pattern is depicted in Figure Figure2,2, as the cumulative proportion of subjects recovered from an episode over time. Figure Figure33 shows the corresponding recovery rates, rather than the cumulative proportion recovered. Figure Figure44 presents the cumulative probability of relapse after single and recurrent episodes.

Figure 1
Age-specific incidence rates from the calibrated simulation model.
Figure 2
Cumulative probability of recovery.
Figure 3
Recovery rate, by episode duration.
Figure 4
Cumulative frequency of relapse, by time since last episode.

The Dspace link that connects to the Flash video file may be found here [11]. A dramatic reduction in point prevalence is seen in association with effective tertiary prevention, because of a lower proportion of subjects in the recurrent episode states in a recurrence at any point in time. Two longer simulation intervals (each about 2.5 minutes) can be found here [12]. These again present the basic calibrated model (first) followed by the depiction of effective tertiary prevention (second), except that an Arena "dashboard" has been added, so that key model parameters are monitored on the bottom of the screen. The simulations need to be fairly long, because the animations reflect stochastic fluctuations in the model outputs. Mean values for n = 100 simulations are presented in Table Table3.3. Table Table33 also presents the calibrated model with a relative risk for mortality of 1.8 (centre column). As expected, the higher mortality in depression leads to slightly lower point prevalence, but most of the parameters are very similar. A set of n = 100 replications of the model with effective tertiary prevention is also presented in Table Table33 (right column). Here, effective tertiary prevention is defined as a reduction in the recurrence rate for people with highly recurrent (≥ 3 episodes) disorders to the same recurrence rate as those who have had only one past episode.

Table 3
Mean values for model parameters (%), after N = 100 replications

As expected, mortality has an effect on point prevalence, but the large change in associated mortality has only a small effect. On the other hand, changing the recurrence rate has a large effect on point prevalence.

Sensitivity analyses

A variety of analyses linking model variables (e.g. scale and shape parameters from the Weibull distributions) to incidence, recurrence and prevalence are presented in Appendix II, see Additional file 2. This Appendix also contains a series of simulations, each with n = 25 replications showing the effect on point prevalence of alteration to various model parameters.

Discussion

The simulation model presented represents a crude synthesis of available data about the epidemiology of major depression. Rather than accept lifetime prevalence estimates made directly from epidemiological studies, thereby ignoring evidence of recall bias that is likely to affect such estimates [13], an estimate of the probable lifetime prevalence based on a combination of incidence and prevalence data from Kruijshaaar [3] was used. The mortality estimate is also somewhat arbitrary. Prior studies pointed towards a higher relative risk for mortality in subjects with major depression, but these are almost certainly over-estimates, as their samples consisted of hospitalized clinical subjects, see Additional file 1 (Appendix I). However, the estimate adopted here is somewhat arbitrary. A sensitivity analysis does not indicate that this makes a large difference to the simulation model, see Additional file 2 (Appendix II). Similarly, values for episode duration and recurrence rates that were used to calibrate the module represent reasonable values given published estimates. The rates of recovery from episodes as depicted here are lower than those reported from a Canadian data source, the National Population Health Survey [4]. However, this study used a brief diagnostic instrument which may have picked up some sub-clinical cases [14].

Despite these limitations, an understanding of certain key elements of major depression epidemiology has solidified during the past decade: recurrence is greater than first incidence, incidence is high in young people, and declines with age, the recovery and remission rates are time dependent. The model reflects all of these elements of the condition. The model presents a visual impression of the interaction between a reasonable set of assumptions about the epidemiology of the condition.

Conclusion

The epidemiology of major depression is complex, and models that attempt to reflect this complexity may have a diminished impact because of their own inherent complexity. Depiction of a simulation model as a visual animation may assist with communicating its implications to a broad audience. Animations of this sort may also be helpful for patient education, and enhanced compliance as they illustrate some of the evidence for therapeutic recommendations. The results presented here are consistent with a conception of major depression as a chronic, recurrent condition [15] and suggest that relevant long-term strategies can have a large impact on population health status.

Competing interests

The author(s) declare that they have no competing interests.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-244X/7/23/prepub

Supplementary Material

Additional file 1:
Additional file 2:

Acknowledgements

Dr. Patten is a Health Scholar with the Alberta Heritage Foundation for Medical Research and a Research Fellow with the Institute of Health Economics.

References

  • Patten SB, Lee RC. Refining estimates of major depression incidence and episode duration in Canada using a Monte Carlo Markov model. Med Decis Making. 2004;24:351–358. doi: 10.1177/0272989X04267008. [PubMed] [Cross Ref]
  • Patten SB, Lee RC. Describing the longitudinal course of major depression using Markov models: Data integration across three national surveys. Popul Hlth Metr. 2005;3:11. doi: 10.1186/1478-7954-3-11. [PMC free article] [PubMed] [Cross Ref]
  • Kruijshaar ME, Barendregt J, Vos T, de Graaf R, Spijker J, Andrews G. Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias. Eur J Epidemiol. 2005;20:103–111. doi: 10.1007/s10654-004-1009-0. [PubMed] [Cross Ref]
  • Patten SB. A major depression prognosis calculator based on episode duration. Clin Pract Epidemiol Mental Hlth. 2006;2:13. doi: 10.1186/1745-0179-2-13. [PMC free article] [PubMed] [Cross Ref]
  • Waraich PS, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49:124–138. [PubMed]
  • Andrews G, Poulton R, Skoog I. Lifetime risk of depression: restricted to a minority or waiting for most? Br J Psychiatry. 2005;187:495–496. doi: 10.1192/bjp.187.6.495. [PubMed] [Cross Ref]
  • Arena. Sewickley, PA, Rockwell Software Inc.; 2006. http://www.arenasimulation.com
  • Canada S. E-Stat. 2006. http://www.statcan.ca/english/Estat/licence.htm
  • Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6–17. [PubMed]
  • Patten SB, Wang JL, Williams JV, Currie S, Beck CA, Maxwell CJ, El-Guebaly N. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51:84–90. [PubMed]
  • Patten SB. Visual animation of major depression epidemiology. University of Calgary Dspace; 2007. http://hdl.handle.net/1880/44649
  • Patten SB. An Animation of Major Depression Epidemiology (with Arena dashboards) University of Calgary DSpace; 2007. http://hdl.handle.net/1880/44475
  • Andrews G, Anstey K, Brodaty H, Issakidis C, Luscombe G. Recall of depressive episode 25 years previously. Psychol Med. 1999;29:787–791. doi: 10.1017/S0033291799008648. [PubMed] [Cross Ref]
  • Patten SB, Brandon-Christie J. Devji J, Sedmak B. Performance of the Composite International Diagnostic Interview Short Form for Major Depression in a community sample. Chron Dis Can. 2000;21:68–72. [PubMed]
  • Andrews G. Should depression be managed as a chronic disease? Br Med J. 2001;332:419–421. doi: 10.1136/bmj.322.7283.419. [PMC free article] [PubMed] [Cross Ref]

Articles from BMC Psychiatry are provided here courtesy of BioMed Central
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...